These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2942521)

  • 41. Enhancement of human T lymphocyte functions by prothymosin alpha. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses.
    Baxevanis CN; Reclos GJ; Panneerselvam C; Papamichail M
    Immunopharmacology; 1988; 15(2):73-84. PubMed ID: 2967267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of synthetic thymosin-alpha 1 and its analogs on fertilizability of human sperm: search for a biologically active, stable epitope.
    Naz RK; Kaplan P; Badamchian M; Goldstein AL
    Arch Androl; 1995; 35(1):63-9. PubMed ID: 8554434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action.
    Conteas CN; Mutchnick MG; Palmer KC; Weller FE; Luk GD; Naylor PH; Erdos MR; Goldstein AL; Panneerselvam C; Horecker BL
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3269-73. PubMed ID: 2375791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of murine thymocyte cytotoxic T cell responses by thymosin.
    Zatz MM; Goldstein AL
    Immunopharmacology; 1983 Jun; 6(1):65-74. PubMed ID: 6603447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
    Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
    Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation changes in cord blood T lymphocytes induced by synthetic C-terminal peptides of thymosin alpha 1.
    Ho AD; Stehle B; Birr C; Heinzel W; Nebe TC
    Thymus; 1987; 9(2):77-84. PubMed ID: 3035761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-2 production and effect of thymosin fraction 5 on interleukin-2 production in rheumatoid arthritis.
    Wolf RE; Hall VC
    J Rheumatol; 1987 Oct; 14(5):898-901. PubMed ID: 3123674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of thymosin alpha one on specific antibody response and susceptibility to infection in young and aged mice.
    Ershler WB; Hebert JC; Blow AJ; Granter SR; Lynch J
    Int J Immunopharmacol; 1985; 7(4):465-71. PubMed ID: 4044090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of thymosin on glucocorticoid receptors in lymphoid cells.
    Osheroff PL
    Cell Immunol; 1981 May; 60(2):376-85. PubMed ID: 6972268
    [No Abstract]   [Full Text] [Related]  

  • 50. Thymosin activity in patients with cellular immunodeficiency.
    Wara DW; Goldstein AL; Doyle NE; Ammann AJ
    N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts.
    Li CL; Zhang T; Saibara T; Nemoto Y; Ono M; Akisawa N; Iwasaki S; Maeda T; Onishi S
    Int Immunopharmacol; 2002 Jan; 2(1):39-46. PubMed ID: 11789668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restoration of delayed hypersensitivity to sheep erythrocytes by thymosin treatment of T-cell-depleted mice.
    Collins FM; Morrison NE
    Infect Immun; 1976 Feb; 13(2):564-8. PubMed ID: 1083376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.
    Shrivastava P; Singh SM; Singh N
    J Biomed Sci; 2004; 11(5):623-30. PubMed ID: 15316138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aging and immunity in non-human primates. II. Lymphocyte response in thymosin treated middle-aged monkeys.
    Ershler WB; Coe CL; Laughlin N; Klopp RG; Gravenstein S; Roecker EB; Schultz KT
    J Gerontol; 1988 Sep; 43(5):B142-6. PubMed ID: 3262133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
    Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
    Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of synthetic thymic hormones on the cocaine-induced inhibition of the primary immune response in mice.
    Ravagnan G; Falchetti R; Lanzilli G; Di Francesco P; Gaziano R; Favalli C; Garaci E
    Int J Immunopharmacol; 1993 Nov; 15(8):879-85. PubMed ID: 8253538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptors for thymosin alpha 1 on mouse thymocytes.
    Rinaldi Garaci C; Torrisi MR; Jezzi T; Frati L; Goldstein AL; Garaci E
    Cell Immunol; 1985 Mar; 91(1):289-93. PubMed ID: 3882244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved ELISA to measure thymosin alpha 1: comparison of whole and absorbed antisera.
    Wada S; Naylor PH; Naylor CW; Goldstein AL
    Int J Immunopharmacol; 1988; 10(7):795-801. PubMed ID: 3235237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunoregulation during aging].
    Doria G
    Recenti Prog Med; 1988; 79(7-8):310-3. PubMed ID: 2974170
    [No Abstract]   [Full Text] [Related]  

  • 60. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T; Pecht M; Trainin N
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.